Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pharmaceutical Vaneck ETF (PPH)

Pharmaceutical Vaneck ETF (PPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 178,718,100
  • Shares Outstanding, K 2,638
  • 60-Month Beta 0.88
Trade PPH with:
  • Price/Earnings ttm 24.05
  • Annual Dividend & Yield 1.11
  • Most Recent Dividend 0.266
  • Management Fee 0.35%
  • Sectors:

    ETFs - Healthcare

Options Overview

Details
  • Implied Volatility 21.52%
  • Historical Volatility 11.61%
  • IV Percentile 24%
  • IV Rank 7.22%
  • IV High 133.34% on 03/16/20
  • IV Low 15.78% on 11/24/20
  • Put/Call Vol Ratio 0.79
  • Today's Volume 25
  • Volume Avg (30-Day) 223
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 11
  • Open Int (30-Day) 498

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.92 unch
on 03/03/21
70.47 -5.04%
on 02/16/21
-1.98 (-2.87%)
since 02/03/21
3-Month
64.86 +3.17%
on 12/21/20
71.15 -5.95%
on 01/26/21
+1.30 (+1.98%)
since 12/03/20
52-Week
46.90 +42.69%
on 03/23/20
71.15 -5.95%
on 01/26/21
+6.62 (+10.98%)
since 03/03/20

Most Recent Stories

More News
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 156.54 (-1.56%)
PFE : 33.85 (+1.01%)
MRK : 72.61 (-0.33%)
LLY : 200.42 (-1.82%)
BMY : 60.07 (-1.96%)
PPH : 66.78 (-1.56%)
PJP : 75.67 (-1.30%)
IHE : 175.67 (-1.81%)
XPH : 52.64 (-1.50%)
FTXH : 25.37 (-1.74%)
Announcing VanEck Vectors ETFs' December 2020 Distributions

VanEck announced today its distributions per share for its VanEck Vectors(R) exchange-traded funds.

ANGL : 32.06 (-0.22%)
PPH : 66.78 (-1.56%)
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

ALXN : 149.05 (-0.88%)
AZN : 47.06 (-1.40%)
PPH : 66.78 (-1.56%)
BBH : 175.23 (-1.37%)
FBT : 163.10 (-2.56%)
PJP : 75.67 (-1.30%)
PBE : 72.00 (-3.20%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 66.78 (-1.56%)
NVO : 71.21 (-2.02%)
AZN : 47.06 (-1.40%)
BMY : 60.07 (-1.96%)
PJP : 75.67 (-1.30%)
IHE : 175.67 (-1.81%)
ETFs to Shine on Lilly's Coronavirus Antibody Progress

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 66.78 (-1.56%)
PJP : 75.67 (-1.30%)
IHE : 175.67 (-1.81%)
XPH : 52.64 (-1.50%)
3 Reasons to Bet on Healthcare ETFs

The broader medical sector should be in the spotlight now on hopes of a coronavirus vaccine and the likelihood of a divided congress.

AZN : 47.06 (-1.40%)
PFE : 33.85 (+1.01%)
GILD : 62.75 (-0.41%)
MRNA : 137.25 (-6.51%)
LLY : 200.42 (-1.82%)
PPH : 66.78 (-1.56%)
PJP : 75.67 (-1.30%)
XPH : 52.64 (-1.50%)
PSCH : 181.22 (-1.68%)
XHS : 102.83 (-0.03%)
FTXH : 25.37 (-1.74%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 66.78 (-1.56%)
NVO : 71.21 (-2.02%)
AZN : 47.06 (-1.40%)
BMY : 60.07 (-1.96%)
PJP : 75.67 (-1.30%)
IHE : 175.67 (-1.81%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 66.78 (-1.56%)
NVO : 71.21 (-2.02%)
AZN : 47.06 (-1.40%)
BMY : 60.07 (-1.96%)
PJP : 75.67 (-1.30%)
IHE : 175.67 (-1.81%)
Here's Why Healthcare ETFs Are Rallying Post Elections

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

IBB : 152.68 (-2.36%)
XLV : 112.24 (-1.33%)
VHT : 222.70 (-1.77%)
XBI : 142.66 (-2.85%)
PPH : 66.78 (-1.56%)
PJP : 75.67 (-1.30%)
Q3 Earnings Fail to Impress Pharma ETFs

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

PPH : 66.78 (-1.56%)
PJP : 75.67 (-1.30%)
IHE : 175.67 (-1.81%)
XPH : 52.64 (-1.50%)
FTXH : 25.37 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 68.49
2nd Resistance Point 68.34
1st Resistance Point 68.09
Last Price 66.78
1st Support Level 67.69
2nd Support Level 67.54
3rd Support Level 67.29

See More

52-Week High 71.15
Last Price 66.78
Fibonacci 61.8% 61.89
Fibonacci 50% 59.03
Fibonacci 38.2% 56.16
52-Week Low 46.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar